Susan Giacalone, MSN, BCMAS, MSL-BC
Vice President, Medical Deployment
Expertise:
Susan leads field medical efforts for EVERSANA. As a leader in the life sciences industry, she brings more than 20 years of medical affairs experience across multiple therapeutic areas, including oncology, hepatology and rare diseases, and she has successfully commercialized products in all market phases. Susan’s career has included numerous senior-level positions, and she earned the MSL Society’s U.S. Manager of the Year award in 2020. Susan holds a bachelor’s degree in nursing from West Chester University in Pennsylvania and a Master of Science in nursing from Wayne State University.
Articles by Susan Giacalone, MSN, BCMAS, MSL-BC
The Future of Personalized, Measurable MSL Engagement
In today’s complex healthcare landscape, Medical Science Liaisons (MSLs) are under pressure to deliver more than trusted relationships. They must provide personalized, data-driven engagement that creates measurable value. While 58% of healthcare professionals rank MSL interactions as more valuable than those with sales representatives, trust alone is no longer enough. With limited time, evolving therapeutic […]
Empowering Scientific Dialogue: Key Takeaways from the FDA’s SIUU Guidance
Discover the latest insights from the FDA’s finalized guidance on Scientific Information on Unapproved Uses (SIUU). This comprehensive document provides a clarified framework for pharmaceutical companies to share scientifically sound information with healthcare providers. In this article, our EVERSANA ONCOLOGY experts explore how to align strategy with compliance while maximizing the impact of data across […]
Navigating the Final FDA SIUU Guidance: Strategic Considerations for Scientific Exchange at ASCO and Other Congresses
The FDA’s finalized guidance on Scientific Information on Unapproved Uses (SIUU) marks a pivotal shift for pharmaceutical companies—offering new clarity and flexibility for engaging healthcare providers in compliant, science-based dialogue. In this POV, EVERSANA ONCOLOGY’s experts explore how to align strategy with compliance while maximizing the impact of data across a variety of scientifically sound […]
Maximizing Medical Affairs and MSL Impact: How Choosing a Strategic Launch Partner Propels Success
Medical Science Liaisons (MSLs) serve as the bridge between pharmaceutical companies, healthcare professionals, and the scientific community. Their impact reverberates across the entire healthcare ecosystem as they are essential for fostering scientific dialogue, driving evidence-based medicine, and advancing patient outcomes. Impact on Newly-Launched Products In her latest article Susan Giacalone, EVERSANA’s Vice President of Medical […]
Incorporating Medical Science Liaisons Early and Often Amplifies Impact and Delivers Stronger Patient Outcomes
The distinctly crucial role Medical Science Liaisons (MSLs) play in the healthcare industry helps ensure success for all stakeholders involved in a patient’s treatment journey. MSLs play a significant role in bridging the gap between scientific knowledge and effectively treating patients, and incorporating their expertise early in the commercialization process is key to achieving adequate […]